Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Nov 15;208(10):1017-1019.
doi: 10.1164/rccm.202309-1546ED.

Improving Outcomes of Chronic Obstructive Pulmonary Disease through the Treatment of Comorbidities: One Step Beyond

Marc Miravitlles  1
Affiliations
Editorial

Improving Outcomes of Chronic Obstructive Pulmonary Disease through the Treatment of Comorbidities: One Step Beyond

Marc Miravitlles. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Representation of the vicious circle of infection, exacerbations, corticosteroid treatment, and Type 2 diabetes mellitus. Pale red circles indicate strategies that may help breaking the vicious circle. COPD = chronic obstructive pulmonary disease; GLP-1RAs = glucagon-like peptide 1 receptor agonists; ICS = inhaled corticosteroid; OCS = oral corticosteroid; SGLT2i = sodium-glucose cotransporter 2 inhibitor.
See this image and copyright information in PMC

Comment on

References

    1. Agustí A, Celli BR, Criner GJ, Halpin D, Anzueto A, Barnes P, et al. Global Initiative for Chronic Obstructive Lung Disease 2023 report: GOLD executive summary. Am J Respir Crit Care Med . 2023;207:819–837. - PMC - PubMed
    1. Lopez-Campos JL, Almagro P, Gómez JT, Chiner E, Palacios L, Hernández C, et al. en nombre del equipo de trabajo de GesEPOC 2021 Actualización de la Guía Española de la EPOC (GesEPOC): comorbilidades, automanejo y cuidados paliativos. Arch Bronconeumol . 2022;58:334–344. - PubMed
    1. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. BODE Collaborative Group Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2012;186:155–161. - PubMed
    1. Cazzola M, Rogliani P, Calzetta L, Lauro D, Page C, Matera MG. Targeting mechanisms linking COPD to type 2 diabetes mellitus. Trends Pharmacol Sci . 2017;38:940–951. - PubMed
    1. Castañ-Abad MT, Montserrat-Capdevila J, Godoy P, Marsal JR, Ortega M, Alsedà M, et al. Diabetes as a risk factor for severe exacerbation and death in patients with COPD: a prospective cohort study. Eur J Public Health . 2020;30:822–827. - PubMed

MeSH terms

Substances